P. Anthony

发表

Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.

P. Cahn, G. Siberry, E. Joao, 2020, The lancet. HIV.

Effect of Cytomegalovirus Co-Infection on Normalization of Selected T-Cell Subsets in Children with Perinatally Acquired HIV Infection Treated with Combination Antiretroviral Therapy

G. Montepiedra, A. Weinberg, A. Kovacs, 2015, PloS one.

Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women

M. Young, P. Tien, W. Mack, 2016, Journal of acquired immune deficiency syndromes.

3BNC117 a Broadly Neutralizing Antibody Suppresses Viremia in HIV-1-Infected Humans

B. Walker, M. Nussenzweig, R. Gorelick, 2016 .

High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088)

S. Spector, G. Siberry, E. Handelsman, 2013, Human vaccines & immunotherapeutics.

Simultaneous plasma and genital pharmacokinetics and pharmacodynamics of atazanavir and efavirenz in HIV‐infected women starting therapy

M. Neely, A. Kovacs, S. Louie, 2015, Journal of clinical pharmacology.

Alteration of select gene expression patterns in individuals infected with HIV‐1

Erik Serrao, N. Neamati, J. Millstein, 2014, Journal of medical virology.

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.

E. Acosta, J. Pinto, R. Hazra, 2022, The lancet. HIV.

Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.

E. Acosta, R. Hazra, R. Viani, 2019, Journal of the Pediatric Infectious Diseases Society.

Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.

S. Spector, R. Yogev, G. Siberry, 2012, The Journal of infectious diseases.

HIV-1 remission and possible cure in a woman after haplo-cord blood transplant

J. Mellors, D. Persaud, N. Tobin, 2023, Cell.

HIV-1 remission and possible cure in a woman after haplo-cord blood transplant

J. Mellors, D. Persaud, N. Tobin, 2023, Cell.

Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia

G. Montepiedra, W. Borkowsky, G. Siberry, 2017, The Pediatric infectious disease journal.

Quantification of Severe Acute Respiratory Syndrome Coronavirus 2 Binding Antibody Levels To Assess Infection and Vaccine-Induced Immunity Using WHO Standards

N. Sood, E. Kawaguchi, A. Kovacs, 2023, Microbiology spectrum.

Multicenter study of QuantiFERON®-TB Gold Plus in patients with active tuberculosis.

P. Kerndt, M. Narita, K. Winthrop, 2018, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial

E. Acosta, J. Pinto, R. Hazra, 2022 .

Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women

M. Young, P. Tien, W. Mack, 2016, Journal of acquired immune deficiency syndromes.